Skip to main content

naproxen

NDC 69097-854 · Cipla USA Inc.

Generic namenaproxen
Dosage formTABLET
RouteORAL
Active ingredient(s)NAPROXEN
Strength375 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

69097-854-07 — 100 TABLET in 1 BOTTLE (69097-854-07)

69097-854-12 — 500 TABLET in 1 BOTTLE (69097-854-12)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68788-7090 — Naproxen, 68788-7946 — Naproxen, 68788-8602 — Naproxen, 68788-8766 — Naproxen and esomeprazole magnesium, 68788-8797 — Naproxen, 68788-8844 — Naproxen, 68788-8906 — Naproxen and esomeprazole magnesium, 69097-851 — Naproxen, 69097-852 — Naproxen, 69097-853 — naproxen, 69097-855 — naproxen, 69238-1730 — Naproxen, 69306-005 — Naproxen and esomeprazole magnesium, 70010-137 — Naproxen, 70010-138 — Naproxen, 70010-139 — Naproxen, 70518-1516 — Naproxen, 70518-3486 — Naproxen, 70518-3822 — Naproxen, 70518-4439 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels